药代动力学指导给药可改善帕唑帕尼真实世界结局
这项前瞻性队列研究在真实临床实践中评估帕唑帕尼治疗药物监测(TDM)的获益。25例接受药代动力学指导给药的患者中仅5例(20%,95%CI 6.8-40.7%)因不良事件停药;历史对照12例中5例(41.7%,95%CI 15.2-72.3%)因不良事件提前终止。PK指导给药较常规给药显著延长中位治疗终止时间(252 vs 74天,P=.012),并降低毒性、改善总生存(未达到 vs 313天,P=.002)。
要点
- PK指导给药组因不良事件停药比例为20%(95%CI 6.8-40.7%),低于历史对照组的41.7%(95%CI 15.2-72.3%)。
- PK指导给药中位治疗终止时间为252天,常规给药为74天(P=.012)。
- PK指导给药组总生存未达到,对照组为313天(P=.002),但样本量小需随机研究验证。
核心结论
- 通过TDM进行PK指导的剂量调整有潜力改善帕唑帕尼在常规临床实践中的治疗结局,值得开展更大规模的随机研究。
研究设计与样本
- 前瞻性队列研究,评估真实临床实践中帕唑帕尼TDM的获益;药代动力学指导给药组25例,历史对照12例。
主要发现
- PK指导给药组因不良事件停药5例(20%,95%CI 6.8-40.7%),历史对照组因不良事件提前终止5例(41.7%,95%CI 15.2-72.3%)。
- PK指导给药较对照组常规给药显著延长中位治疗终止时间(252 vs 74天,P=.012),降低毒性并改善总生存(未达到 vs 313天,P=.002)。
临床怎么用
- 对帕唑帕尼治疗患者可考虑通过TDM进行PK指导的剂量调整,以降低毒性、延长治疗持续时间并改善生存结局。
局限性
- 研究为前瞻性队列设计,对照组为历史对照且仅12例,样本量小,结论需更大规模随机研究验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
It remains unclear whether therapeutic drug monitoring (TDM) of pazopanib improves treatment outcomes in routine clinical practice. We did a prospective cohort study to evaluate the benefits of TDM for pazopanib therapy in real-world practice. Among 25 patients with pharmacokinetically guided dosing, only 5 (20%, 95% confidence interval 6.8-40.7%) discontinued treatment because of adverse events. However, 5 (41.7%, 95% confidence interval 15.2-72.3%) of historical controls including 12 patients not receiving such a strategy experienced adverse events leading to early termination. PK-guided dosing significantly increased median time-to-treatment discontinuation (252 vs 74 days, P = .012) with reduced toxicity and improved overall survival (not reached vs 313 days, P = .002) relative to conventional dosing in the control group. In conclusion, PK-guided dose adaptation through the use of TDM has the potential to improve treatment outcomes of pazopanib in routine clinical practice, warranting larger, randomized studies.
引用
- Fukudo M, Tamaki G, Azumi M, et al. Pharmacokinetically guided dosing has the potential to improve real-world outcomes of pazopanib. Br J Clin Pharmacol. 2020. PMID: 33010046. doi:10.1111/bcp.14580
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。